Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jan 23, 2024--
Source: eagletribune.com
Linkedin Juvena News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Linkedin Juvena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Linkedin Juvena Today - Breaking & Trending Today
Slone Partners Places Gayarthri Swaminath as SVP of Discovery and Edward Moler as VP of Data Science at Juvena Therapeutics
South Riding, VA (PRWEB) February 08, 2023 -- Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies,
Source: prweb.com
Slone Partners Places Gayathri Swaminath as SVP of Discovery and Edward Moler as VP of Data Science at Juvena Therapeutics
South Riding, VA (PRWEB) February 08, 2023 -- Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies,
Source: prweb.com